| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Ms. E. Gao CEO | XSHE Exchange | CNE100002DV1 ISIN |
| CN Country | 2,426 Employees | 22 May 2026 Last Dividend | 22 May 2026 Last Split | - IPO Date |
Shenyang Xingqi Pharmaceutical Co.,Ltd., established in 1977 and headquartered in Shenyang, the People's Republic of China, operates in the pharmaceutical sector with a primary focus on the research, development, production, and sale of ophthalmic medications. Its role in the pharmaceutical industry is emphasized through its engagement in the research and development of eye treatment products, alongside technology development, technical consultation, investment activities, and managing eye hospital businesses. Furthermore, the company plays a significant part in the production and wholesale distribution of pharmaceuticals in China, showcasing its integrated role in the healthcare and medical sectors within the country.
Shenyang Xingqi Pharmaceutical Co.,Ltd. offers a wide range of ophthalmic products catered to various eye conditions and needs:
In addition to its comprehensive range of ophthalmic medications, Shenyang Xingqi Pharmaceutical Co.,Ltd. is involved in technology development and technical consultation. The company also partakes in investment activities and operates eye hospital businesses, suggesting a broad scope of services that extend beyond pharmaceutical production and distribution. These engagements highlight the company's holistic approach to tackling eye health issues, underlining its commitment to advancing ocular health and wellness through a variety of channels.